Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Juan Luis Catoya Villa"'
Autor:
César Gutiérrez Pérez, Inmaculada Rodríguez Ledesma, Carmen Blanco Abad, Juan Luis Catoya Villa, Irene Chivato Martín-Falquina, Alicia Cuenca Zarzuela, Guillermo Crespo Herrero
Publikováno v:
Gastroenterología y Hepatología.
Autor:
César, Gutiérrez Pérez, Inmaculada, Rodríguez Ledesma, Carmen, Blanco Abad, Juan Luis, Catoya Villa, Irene, Chivato Martín-Falquina, Alicia, Cuenca Zarzuela, Ana María, López Muñoz
Publikováno v:
Revista Española de Enfermedades Digestivas.
We present the case of a 38-year-old woman who, in the context of a 22-week gestation, was diagnosed with diffuse gastric adenocarcinoma. The age of the patient and the way in which the cancer presented itself, make genetic counseling mandatory to ru
Autor:
Pilar Garcia-Alfonso, Natalia Gutiérrez Alonso, Marianela Bringas Beranek, Javier Soto Alsar, Carlos López Jiménez, Ana Gutierrez Ortiz de la Tabla, Roberto Jiménez Rodríguez, Rocío Martín Lozano, César Gutiérrez Pérez, Manuel Alva Bianchi, Andrés J. Muñoz Martín, Gabriela Torres Pérez-Solero, Laura Ortega, Aitana Calvo Ferrándiz, Juan Luis Catoya Villa, Marta Arregui Valles, Inmaculada Aparicio Salcedo, Miguel Martin
Publikováno v:
Journal of Clinical Oncology. 40:e15552-e15552
e15552 Background: BRAF mutated mCRC patients have worse prognosis compared with BRAF wildtype mCRC. Within this group, those with resectable disease have a better prognosis compared to those with unresectable disease. However, it is not well known w
Autor:
Javier Soto, Natalia Gutiérrez Alonso, Marianela Bringas Beranek, Juan Luis Catoya Villa, Ana Gutierrez Ortiz de la Tabla, Carlos López Jiménez, Manuel Alva Bianchi, Roberto Jiménez Rodríguez, Rocío Martín Lozano, Marta Arregui Valles, Inmaculada Aparicio Salcedo, Laura Ortega Morán, Gabriela Torres Pérez-Solero, Andrés J. Muñoz Martín, Aitana Calvo Ferrándiz, Montserrat Blanco Codesido, Íñigo Martínez Delfrade, David Salomon Juliao Caamaño, Miguel Martin, Pilar Garcia-Alfonso
Publikováno v:
Journal of Clinical Oncology. 40:59-59
59 Background: Over the last decades the incidence of EOCRC (age 50 or less) has dramatically increased, and so has the scientific interest in this field, given that clinical and molecular characteristics in these patients are not well understood, an